Clinical Trial Update: Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/Phase 2 clinical trial assessing the safety and efficacy of BEY1107 in combination with gemcitabine for locally advanced or metastatic pancre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• BEY1107
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: BeyondBio Inc. | Conditions: Locally Advanced or Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING